Molecular Therapy
Volume 1 • Issue 12
- ISSN: 1525-0016
- 5 Year impact factor: 11.8
- Impact factor: 12.1
Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-,… Read more
Subscription options
Institutional subscription on ScienceDirect
Request a sales quoteMolecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2022 impact factor is 12.4.
To accommodate the rapid growth of Molecular Therapy, articles will be submitted and published in one of the following subsections (for section editors, please see the editorial board page):
Biomarker and therapeutic target identification
Cell therapy
Clinical gene and cell therapies
Epigenome editing
Genome editing
Immunotherapy
Molecular diagnostics and imaging
Non-viral gene therapy
RNA therapies
Small-molecule therapies
Vaccine development
Viral gene therapy
Visit the Cell Press website for more information about Molecular Therapy - http://www.cell.com/molecular-therapy-family/home
- ISSN: 1525-0016
- Volume 1
- Issue 12
- 5 Year impact factor: 11.8
- Impact factor: 12.1